Michael A. Repka

401 total citations
6 papers, 306 citations indexed

About

Michael A. Repka is a scholar working on Biomedical Engineering, Molecular Biology and Automotive Engineering. According to data from OpenAlex, Michael A. Repka has authored 6 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Biomedical Engineering, 2 papers in Molecular Biology and 2 papers in Automotive Engineering. Recurrent topics in Michael A. Repka's work include Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), 3D Printing in Biomedical Research (3 papers) and Additive Manufacturing and 3D Printing Technologies (2 papers). Michael A. Repka is often cited by papers focused on Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), 3D Printing in Biomedical Research (3 papers) and Additive Manufacturing and 3D Printing Technologies (2 papers). Michael A. Repka collaborates with scholars based in United States, Germany and Finland. Michael A. Repka's co-authors include Jiaxiang Zhang, Anh Q. Vo, Maren Preis, Heidi Öblom, Manjeet B. Pimparade, Niklas Sandler, Suresh Bandari, Xinliang Feng, Siva Ram Kiran Vaka and Meiwan Chen and has published in prestigious journals such as Pharmaceutical Research, Journal of Pharmacy and Pharmacology and Expert Opinion on Drug Delivery.

In The Last Decade

Michael A. Repka

6 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Repka United States 6 190 138 60 47 46 6 306
Branko Vukosavljević Germany 9 217 1.1× 152 1.1× 65 1.1× 92 2.0× 52 1.1× 13 406
Sen Qiao China 10 247 1.3× 140 1.0× 42 0.7× 71 1.5× 29 0.6× 11 334
Zhufen Lv China 9 202 1.1× 142 1.0× 76 1.3× 67 1.4× 42 0.9× 15 364
Kiran Yellappa Vajanthri India 10 191 1.0× 67 0.5× 65 1.1× 159 3.4× 107 2.3× 15 448
Niloofar Heshmati Aghda United States 9 258 1.4× 138 1.0× 32 0.5× 55 1.2× 39 0.8× 11 340
Shrawani Lamichhane South Korea 10 164 0.9× 105 0.8× 121 2.0× 84 1.8× 98 2.1× 10 394
Weigang Wu China 9 233 1.2× 155 1.1× 24 0.4× 51 1.1× 22 0.5× 14 326
Mengsuo Cui China 15 518 2.7× 388 2.8× 168 2.8× 70 1.5× 39 0.8× 18 685
Amr Maged Egypt 10 167 0.9× 65 0.5× 127 2.1× 95 2.0× 28 0.6× 13 399
Prashant Pingale India 10 91 0.5× 31 0.2× 109 1.8× 113 2.4× 60 1.3× 38 361

Countries citing papers authored by Michael A. Repka

Since Specialization
Citations

This map shows the geographic impact of Michael A. Repka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Repka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Repka more than expected).

Fields of papers citing papers by Michael A. Repka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Repka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Repka. The network helps show where Michael A. Repka may publish in the future.

Co-authorship network of co-authors of Michael A. Repka

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Repka. A scholar is included among the top collaborators of Michael A. Repka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Repka. Michael A. Repka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Zhang, Jiaxiang, et al.. (2021). Oral drug delivery systems using core–shell structure additive manufacturing technologies: a proof-of-concept study. Journal of Pharmacy and Pharmacology. 73(2). 152–160. 5 indexed citations
2.
Öblom, Heidi, Jiaxiang Zhang, Manjeet B. Pimparade, et al.. (2019). 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release. AAPS PharmSciTech. 20(2). 52–52. 126 indexed citations
3.
Li, Yusheng, et al.. (2018). Interactions Between Biological Products and Product Packaging and Potential Approaches to Overcome Them. AAPS PharmSciTech. 19(8). 3681–3686. 17 indexed citations
4.
Zhang, Jiaxiang, Anh Q. Vo, Xinliang Feng, Suresh Bandari, & Michael A. Repka. (2018). Pharmaceutical Additive Manufacturing: a Novel Tool for Complex and Personalized Drug Delivery Systems. AAPS PharmSciTech. 19(8). 3388–3402. 82 indexed citations
5.
Wang, Shengpeng, et al.. (2014). mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer. Expert Opinion on Drug Delivery. 12(3). 361–373. 44 indexed citations
6.
Vaka, Siva Ram Kiran, et al.. (2011). Delivery of Brain-Derived Neurotrophic Factor via Nose-to-Brain Pathway. Pharmaceutical Research. 29(2). 441–447. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026